Fixed-drug eruption caused by allylisopropylacetylurea

Contact Dermatitis

Volumn 44, Issue 3, 2001, Pages 189-190

  Sakakibara, Takako ^a   Hata, Mieko ^a   Numano, Kayok ^a   Kawase, Yoko ^a   Yamanishi, Takahito ^b   Kawana, Seiji ^b   Tsuboi, Narumi ^b  

^a NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Allylisopropylacetylurea; Bromvalerylurea; Cross sensitization; Cutaneous adverse drug reactions; Fixed drug eruption; Hypnotics and sedatives; Positive lesional patch test

Indexed keywords

ANALGESIC AGENT; APRONAL; CAFFEINE; EVEA; IBUPROFEN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG ERUPTION; DRUG FORMULATION; DRUG STRUCTURE; FEMALE; HERPES SIMPLEX; HUMAN; PATCH TEST; PROVOCATION TEST; RECURRENT DISEASE;

ADULT; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; FEMALE; HERPES GENITALIS; HUMANS; HYPNOTICS AND SEDATIVES; PAIN; PATCH TESTS; UREA;

EID: 0035150720     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0536.2001.440308-10.x     Document Type: Article

References (8)

1. A case of fixed drug eruption due to bromvalerylurea; ingredient of Coughcode
2. A fixed drug eruption due to allylisopropylacetylurea
3. 2 cases of fixed drug eruption due to allylisopropylacetylurea
4. Fixed drug eruption due to allylisopropylacetylurea: Report of a case
5. A case of fixed drug eruption due to allylisopropylacetylurea
6. A case of fixed drug eruption due to allylisopropylacetylurea
7. A case of fixed drug eruption due to allylisopropylacetylurea
8. A case of fixed drug eruption due to allylisopropylacetylurea